Order Information
Contact us
Insert title here
Featured Products
HY-10087  |  Navitoclax
HY-10128  |  ZM-447439
HY-10161  |  Tozasertib
HY-10180  |  MLN8054
HY-10192  |  NVP-TAE 684
HY-10249  |  GSK-690693
HY-10355  |  AKT inhibitor VIII
HY-10358  |  MK 2206 (dihydrochloride)
HY-11002  |  CP-466722
HY-11007  |  GNF-2
HY-50662  |  A-769662
HY-50907  |  ABT-737
HY-70061  |  Aurora A inhibitor I


 (Synonyms  MK-2206 dihydrochloride;MK2206 dihydrochloride)
1032350-13-2  Technical Data: Price and Availability of  Cas No:1032350-13-2

Cas : 1032350-13-2 M.Wt: 480.389
Cas : 1032350-13-2 Formula: C25H23Cl2N5O
Cas : 1032350-13-2 Purity: >98 %
Cas : 1032350-13-2 Storage: at 20℃ 2 years
Cas : 1032350-13-2 Solubility: DMSO
Cas : 1032350-13-2 Name: MK 2206 (dihydrochloride)
5mg/$80 In-stock
10mg/$110 In-stock
50mg/$260 In-stock
100mg/$400 In-stock
1g Get quote
5g Get quote
>10g Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please
inquire via sales@chemexpress.cn
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
Online Inquiry
1032350-13-2  Data Sheet:
Introduction of 1032350-13-2 :
MK 2206 is an orally active allosteric Akt inhibitor with IC50 of 5 nM/12 nM/65 nM for Akt1/2/3, respectively. IC50 & Target: IC50: 5 nM/12 nM/65 nM (Akt1/2/3)[1] In Vitro: The NPC cell lines CNE-1, CNE-2, HONE-1, and SUNE-1 are treated with increasing doses of MK-2206 (0-10 μM) for 72 and 96 hours, results in dose- and time-dependent inhibition of cell viability. At 72 and 96 hours, the IC50 values of MK-2206 in CNE-1, CNE-2, and HONE-1 cell lines are 3-5 μM, and in SUNE-1, they are less than 1 μM[1]. MK-2206 alone more potently inhibits the cell growth of Ras wild-type (WT) cell lines (A431, HCC827, and NCI-H292; IC50s of 5.5, 4.3, and 5.2 μM, respectively) as compared with Ras-mutant cell lines (NCI-H358, NCI-H23, NCI-H1299, and Calu-6; IC50s of 13.5, 14.1, 27.0, and 28.6 μM, respectively), with the exception of NCI-H460, which has a PIK3CA E545K mutation (IC50, 3.4 μM)[2]. In Vivo: MK-2206 doses (480 mg/kg once a week and 240 mg/kg three times a week) can inhibit the growth of human CNE-2 xenografts in nude mice. In the two MK-2206 groups, the tumor weights are much lighter than the control group (P<0.01). Temporal body weight reduction is observed after receiving the MK-2206 treatment[1].
References on 1032350-13-2 :

Keywords: buy MK 2206 (dihydrochloride) | MK 2206 (dihydrochloride) Supplier | purchase MK 2206 (dihydrochloride) | MK 2206 (dihydrochloride) cost | MK 2206 (dihydrochloride) manufacturer | order MK 2206 (dihydrochloride) | MK 2206 (dihydrochloride) distributor | MK 2206 (dihydrochloride) structure
buy 1032350-13-2 | 1032350-13-2 Supplier | purchase 1032350-13-2 | 1032350-13-2 cost | 1032350-13-2 manufacturer | order 1032350-13-2 | 1032350-13-2 distributor | 1032350-13-2 structure
Insert title here
Products are for research use only. Not for human use. We do not sell to patients.           Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China  
86-21-58998590   FAX: 86-21-53700326, 86-21-58998590   E-mail: sales@chemexpress.cn